These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4965190)

  • 41. Opsonizing properties of horse sera. I. Opsonization of staphylococci (Staph. aureus).
    Grzybek-Hryncewicz K; Ladosz J; Kubis K; Slopek S
    Arch Immunol Ther Exp (Warsz); 1966; 14(1):15-8. PubMed ID: 5919020
    [No Abstract]   [Full Text] [Related]  

  • 42. Feline (cat) hemolytic complement optimal testing conditions.
    Barta O; Oyekan PP
    Am J Vet Res; 1981 Mar; 42(3):378-81. PubMed ID: 6791533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antibacterial effect of neomycin, quaternary ammonium compounds and combinations of these substances on Pseudomonas aeruginosa.
    Tăborsky I; Nezval J; Smékal E; Janisch R
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):359-67. PubMed ID: 4980473
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum opsonin, bacteria, and polymorphonuclear leukocyte interactions in subacute bacterial endocarditis. Anti-gamma-globulin factors and their interaction with specific opsonins.
    Messner RP; Laxidal T; Quie PG; Williams RC
    J Clin Invest; 1968 May; 47(5):1109-20. PubMed ID: 5645856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between phagocytosis of polystyrene latex particles by polymorphonuclear leucocytes (PML) and aggregation of PML.
    Talstad I
    Scand J Haematol; 1972; 9(5):516-23. PubMed ID: 4116375
    [No Abstract]   [Full Text] [Related]  

  • 46. Ultracentrifugation of the first component of complement: effects of ionic strength.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1968 Apr; 100(4):808-13. PubMed ID: 4967046
    [No Abstract]   [Full Text] [Related]  

  • 47. [Correlation between the loss of plasmid DNA and the transition from virulent phase I to avirulent phase II in Shigella sonnei].
    Sansonetti P; David M; Toucas M
    C R Seances Acad Sci D; 1980 Mar; 290(13):879-82. PubMed ID: 6771038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Failure of bovine complement levels measured by radial hemolysis to correlate with tube titration.
    Nielsen K; Rosenbaum B; Harper S; Adams LG; Williams JD
    Am J Vet Res; 1983 Oct; 44(10):1935-7. PubMed ID: 6416118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
    J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phagocytosis as a surface phenomenon.
    van Oss CJ
    Annu Rev Microbiol; 1978; 32():19-39. PubMed ID: 360965
    [No Abstract]   [Full Text] [Related]  

  • 52. The antigenic structure of phase I and II of Sh. sonnei.
    Rauss K; Kontrohr T
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):95-8. PubMed ID: 5338322
    [No Abstract]   [Full Text] [Related]  

  • 53. Neutralization of bacterial viruses by antibodies of young animals. II. Studies on the cofactor activity of complement from precolostral piglet serum: comparison with the haemolytic and bactericidal activity.
    Hájek P
    Folia Microbiol (Praha); 1969; 14(6):595-601. PubMed ID: 4984619
    [No Abstract]   [Full Text] [Related]  

  • 54. Outer membrane proteins of Shigella sonnei. I. Characterization of phase I, phase II and R-form Shigella sonnei.
    Adamus G; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):547-52. PubMed ID: 7006562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytes.
    Guckian JC; Christensen GD; Schweinle JE; Fine DP
    J Immunol; 1981 Oct; 127(4):1659-65. PubMed ID: 7276577
    [No Abstract]   [Full Text] [Related]  

  • 56. [Obtaining dysentery and salmonellosis diagnostica for the coagglutination reaction in lyophilized form and the elaboration of a rapid system].
    Belaia IuA; Belaia OF
    Lab Delo; 1982; (8):486-8. PubMed ID: 6182376
    [No Abstract]   [Full Text] [Related]  

  • 57. Blood serum factors associated with erythrophagocytosis in calves with anaplasmosis.
    Schroeder WF; Ristic M
    Am J Vet Res; 1968 Oct; 29(10):1991-5. PubMed ID: 5692891
    [No Abstract]   [Full Text] [Related]  

  • 58. Rabbit platelet injury by soluble antigen and antibody. 3. Effects of the sodium and magnesium salts of EDTA and EGTA.
    Marney SR; Prez RM
    J Immunol; 1971 Jun; 106(6):1447-52. PubMed ID: 4997241
    [No Abstract]   [Full Text] [Related]  

  • 59. Free endotoxin of Shigella sonnei phase I.
    Slopek S; Romanowska E; Gieldanowski J; Mulczyk M; Godzińska H
    Bull Acad Pol Sci Biol; 1969; 17(2):81-3. PubMed ID: 4911443
    [No Abstract]   [Full Text] [Related]  

  • 60. Receptor sites for complement on certain human peripheral blood lymphocytes.
    Michlmayr G; Huber H
    J Immunol; 1970 Sep; 105(3):670-6. PubMed ID: 4989556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.